Table: Hisamitsu -Q1 group results
Jul 6 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
May 31, 2018 May 31, 2017 Feb 28, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 33.50 36.08 148.50
(-7.2 pct) (-5.4 pct) (+0.4 pct)
Operating 4.35 5.09 24.00
(-14.4 pct) (-11.4 pct) (-8.9 pct)
Recurring 4.45 4.94 26.30
(-10.0 pct) (-11.2 pct) (-6.9 pct)
Net 3.45 3.67 19.20
(-6.0 pct) (-18.9 pct) (+0.4 pct)
EPS 41.27 yen 43.92 yen 229.49 yen
EPS Diluted 41.23 yen 43.89 yen
Ann Div 82.00 yen 82.50 yen
-Q2 div 41.00 yen 41.25 yen
-Q4 div 41.00 yen 41.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO